The Cas-Br-E murine leukemia virus (MuLV) induces a degenerative myeloencephalopathy leading to hindlimb paralysis when inoculated into newborn mice. To map the viral DNA sequences encoding the determinant of neurological degeneration, we constructed chimeric viruses in vitro with parental genomes from Cas-Br-E MuLV and from nonparalytogenic MuLVs. We found that a 1.5-kilobase-pair env Cas-Br-E fragment was sufficient to confer the full paralysis-inducing potential to chimeric viruses. This region encodes the 19 carboxyl-terminal residues of the leader sequence, all of gp7O, and the 45 amino-terminal residues of the transmembrane protein (pl5E). Within this env region, we identified a 372-base-pair fragment which was necessary for the full paralysis-inducing potential of the virus and which influenced the development of the disease in a strain-dependent manner. This domain encodes the 19 carboxyl-terminal residues of the leader peptide and the first 67 amino-terminal residues of gp7O. We propose that Cas-Br-E MuLV induces spongiform degeneration through binding of its gp7O to a specific cellular receptor.
The Cas-Br-E wild mouse ecotropic murine leukemia virus (MuLV) has been shown to induce a progressive form of hind-limb paralysis after inoculation into susceptible laboratory mice (for review, see refs. 1 and 2) . This clinical syndrome is the consequence of a spongiform myeloencephalopathy predominantly involving the brainstem and the anterior horn of the lumbosacral region of the spinal cord (3) (4) (5) (6) . Using chimeric viruses constructed in vitro, we have previously mapped the primary determinant of this spongiform degeneration within a 3.9-kilobase-pair (kbp) pol-env fragment of the viral genome (7) . Sequencing of this region revealed that the pol gene product and piSE diverged very little from homologous proteins of other nonparalytogenic MuLVs, while the Cas-Br-E gp7O sequence was found to diverge significantly from that of other nonparalytogenic MuLVs (8) . We also showed that the long terminal repeat (LTR) region of the genome harbors a second determinant of pathogenicity influencing the incidence of the disease and determining in which region of the central nervous system (CNS) this virus induces the spongiform lesions (9) .
To determine more precisely which viral gene harbors the primary determinant of the spongiform lesions, we constructed additional chimeric viruses with DNA from parental paralytogenic Cas-Br-E and nonparalytogenic amphotropic, endogenous ecotropic, or Moloney MuLVs. We show here that chimeric viruses harboring only the env gene of Cas-Br-E MuLV genome induce spongiform lesions and remain paralytogenic.
MATERIALS AND METHODS
Mice. SWR/J pregnant females were purchased from The Jackson Laboratory. SIM.S and NFS/N mice were from our breeding colony. The virus suspensions were filtered through a HAWP nitrocellulose filter (pore size, 0.45 um; Millipore) and injected intraperitoneally (0.15 ml) into newborn (<48 hr) mice.
Cells and Viruses. The Cas-Br-E (pNE-8) molecularly cloned parental MuLV was described previously (10) . The origin of NIH 3T3 cells has been given elsewhere (10, 11) .
Construction of DNA Recombinants. The cloned viral DNA from Moloney (9) , endogenous N-tropic BALB/c (pBR-7) (12), pNE-8 (10), amphotropic 4070-A (13), and chimeric pNEA-1 (7) MuLVs have been described. Recombinant chimeric DNAs were constructed as described (7, 9, 10) , using pBR322 or pJRD184 (14) as vectors.
Synthetic Oligonucleotides. Oligonucleotides ( Fig. 1 ) were synthesized on an Applied Biosystems model 380A nucleic acid synthesizer, using the solid-phase phosphoramidite chemistry (15) . They were purified on a polyacrylamide/urea gel, annealed, and cloned in pUC18. The double-stranded inserts were sequenced by the dideoxynucleotide method (17) .
Transfection Procedure. The permuted viral inserts were cleaved with appropriate restriction endonucleases and religated to obtain nonpermuted forms of the viral genome. The DNAs (5-10 ,ug) were transfected by the calcium phosphate procedure (18) on NIH/3T3 cells. Viruses recovered from the supernatant of these transfected cells were titered by XC assay (19) or by end-point dilution.
Preparation of Unintegrated Viral DNA. NIH 3T3 cells were cocultivated with chronically infected cells in the presence of Polybrene at 2 kxg/ml. Hirt supernatant DNA was prepared after 48 hr of cocultivation as described (7, 11) . Restriction analysis of unintegrated viral DNA was performed by hydridization of Southern blots with 32P-labeled probes, as described (7, 11 pNE-XT and pNE-XK recombinants harbored only a short region of Cas-Br-E MuLV, respectively from the integrase and the pl5E-LTR regions. Each chosen recombinant was characterized to determine its structure and to confirm the origin of each fragment, using a combination of restriction endonuclease analysis and hybridization with specific probes (data not shown).
Recovery and Characterization of Infectious Chimeric MuLVs. To recover infectious chimeric viruses, the recombinant viral inserts were transfected into NIH 3T3 cells. The recovered viruses were further characterized by restriction endonuclease analysis of their unintegrated viral DNA obtained by Hirt extraction of acutely infected NIH 3T3 cells, using specific probes. Clones pNE-SC, pNE-XT, and pNE-TC, analyzed with the pol probe, showed fragments typical of the 4070A MuLV gag-pol region, namely a 3.7-kbp Xba I fragment (not shown) and a 1.6-kbp HindIII-Sac I fragment (Fig. 3B, lanes 4-6) . With the Cas-Br-E MuLV (pNE-8)-specific env probe, clones pNE-SC and pNE-TC showed a 1065-bp Xba I fragment typical of the pNE-8 envelope, plus a novel 500-bp Xba I fragment spanning the Moloney-pNE-8 MuLV DNA junction (Fig. 3D, lanes 4 and 5) . With the int probe, a 441-bp Xba I fragment typical of Moloney MuLV was detected (Fig. 3C, lanes 4 and 5) . In contrast, the Xba I digest of clone pNE-XT did not give any signal with the env probe (Fig. 3D, lane 6) , as expected, since this genome does not contain this region of the pNE-8 envelope. However, with the int probe, a 3.0-kbp Xba I fragment could be detected, spanning the pol-env-LTR region (Fig. 3C, lane 6 ). In the Xba I digest of the pNE-XC chimeric viral DNA, two fragments (1065 and 940 bp) typical of the env region of the pNE-8 parental DNA were detected (Fig. 3A, lane 3) . With the same DNA, HindIII generated 8.5-and 5.4-kbp fragments (respectively from supercoiled and linear molecules), longer than those of the pNE-8 control (7.5 and 4.2 kbp) (Fig. 3A, lane 1) , indicating that the 5' region of this chimeric virus was not derived from pNE-8 but came from the parental 4070A MuLV.
To confirm the presence of the NE-8 LTR in the pNE-XK chimeric MuLV, the viral DNA was digested with Sac I or Sac I-Cla I and hybridized with the NE-8-specific U3 probe. The pNE-XK DNA hybridized well with this probe, as expected for a molecule containing the LTR from pNE-8; as in the NE-8 control, it shows a band at 5.0 kbp coming from the 3' part of the viral DNA molecule, plus a small, 338-bp, fragment corresponding to the 5' LTR (Fig. 3E, lane 3) . The pNE-8 lane also shows a 521-bp fragment originating from circular molecules carrying two LTRs in tandem. When cut with Sac I plus Cla I, the 5.0-kbp Sac I fragment generated a 480-bp fragment from both DNAs, confirming the presence of a Cla I site in the chimeric molecule (Fig. 3E , lanes S and 6). To prove that the coding region of pNE-XK was derived from the pBR7 parent, this viral DNA was cleaved with Xba I-HindIII and hybridized with a gp7O ecotropic MuLVspecific (eco) probe. In both cases, the pNE-XK DNA showed fragments identical to those of the pBR7 control (Fig.  3E, lanes 1 and 2) . This analysis is illustrated in Fig. 4 .
Paralysis-Inducing Potential of Chimeric MuLVs. To identify the viral sequences responsible for the induction of neurological disease, the chimeric MuLVs were inoculated intraperitoneally into newborn (<48 hr) susceptible SWR/J, SIM.S, or NFS/N mice. Mice were checked frequently for manifestations of the disease (spasticity, tremulousness, hind-limb paralysis, splay reflex), and those showing signs of paralysis were sacrificed a few days before their anticipated death. As shown in Fig. 5 , mice inoculated with pNE-XK or pNE-XT chimeric MuLVs showed no sign of paralysis or other neurological disease more than 200 days after injection, indicating that the integrase, the amino-terminal half of the env leader peptide, and the 3' end of env, encoding most of pl5E, do not harbor the determinant of paralysis. However, these viruses replicated well in vivo, since 8 out of 18 SWR/J and 7 out of 23 SIM.S mice inoculated with pNE-XK MuLV and 3 out of 7 pNE-XT MuLV-inoculated NFS/N or SWR/J mice had lymphomas at the time they were sacrificed. Mice inoculated with pNE-XC or pNE-TC chimeric MuLVs showed a high incidence of paralysis (80-100%), indicating that the env gene (and not the pol gene) harbors the determinant of paralysis. The longer latency seen with pNE-TC MuLV might have been caused by the lower virus titer at injection. SWR/J mice injected with the pNE-SC virus also developed neurologic disease; however, except for 4 of these mice which showed the typical signs of hind-limb paralysis, the majority of them developed a milder form of paralysis which did not progress as rapidly as with the other chimeric viruses or as with the parental Cas-Br-E MuLV. Most (19/21) of these pNE-SC MuLV-inoculated SWR/J also had leukemia. Interestingly, SIM.S mice inoculated with pNE-SC MuLV did not show clinical signs of neurological disease, even though a significant percentage of them (10/22) eventually developed leukemias. These results indicated that the amino-terminal region of Cas-Br-E gp7O is not essential for the appearance of the neurologic disease in SWR/J mice. However, since the substitution of this region led to a less aggressive form of hind-limb paralysis in SWR/J mice and to the absence of neurological disease in SIM.S mice, this 372-bp fragment (Taq I-Xma I) is likely to harbor part of the determinant.
Pathology. Examination ofbrain and spinal cord specimens from four or five mice inoculated with each paralytogenic chimeric MuLV showed spongiform lesions indistinguishable in their appearance and distribution from those induced by the parental Cas-Br-E MuLV (data not shown). Cas-Br-E int protein) and pNE-SC (containing only Cas-Br-E env, but no pol, sequences) MuLVs were still capable of inducing spongiform degeneration. Within the Cas-Br-E MuLV env region we could also identify two regions which appear nonessential for inducing neurological disease. The carboxyl terminus of the transmembrane env-encoded protein (pl5E) seems indeed unlikely to harbor the determinant of paralysis, since the chimeric pNE-XK MuLV (which contains 139 amino acid residues of the carboxyl terminus of Cas-Br-E p15E) was totally incapable of inducing paralysis. In addition, our previous sequencing data (8) showed that the 12 amino acid residues upstream of these 139 amino acid residues were identical in Cas-Br-E and other nonparalytogenic MuLVs. Therefore, the 3' end env border of the paralysis-inducing determinants of Cas-Br-E MuLV does not extend beyond residue 45 of p15E. Since pNE-TC chimeric MuLV was fully paralytogenic, the Taq I site borders the paralysis-inducing determinant at the 5' end of env.
Interestingly, we could also identify a region within env which seems essential for the induction of the complete neurological disease. Comparison of pathogenicity between pNE-TC and pNE-SC chimeric MuLVs indeed showed that pNE-SC MuLV was significantly less pathogenic. The genomes of the two viruses differ by only the 19 carboxylterminal residues of the env leader peptide and by the 67 amino-terminal residues of gp7O encoded between the Taq I and the Xma I sites, indicating that this env domain (86 amino acid residues) harbors at least part of the paralysis-inducing determinant of the virus. However, since pNE-SC MuLV induced paralysis in some SWR/J mice, these 86 aminoterminal residues of env do not seem to be absolutely essential, suggesting that other sequences within env are critical for the induction of this neurological degeneration.
Our combined data indicate that these other sequences lie within a 413-amino-acid env domain, between amino acid residue 68 of gp7O and residue 45 of pl5E. Since the 45 pl5E amino acid residues were previously found to be highly conserved between Cas-Br-E and other nonparalytogenic MuLVs, gp7O remains the best candidate to harbor the determinant of paralysis of Cas-Br-E MuLV. The Cas-Br-E gp7O sequences are highly divergent from those of other nonparalytogenic MuLVs. In contrast to pNE-TC MuLV, (5/5) ( the pNE-SC MuLV was pathogenic for SWR/J mice, but it did not induce clinical neurological disease when inoculated into SIM.S mice, although it replicated in these mice, almost half of them (10/22) eventually developing leukemias. The amino-terminal 86 residues of env seem responsible for this host range of the virus, and they appear to be essential for induction of paralysis in SIM.S mice but not in SWR/J mice. This result suggests that this env domain interacts with a cellular factor(s) that is (are) critical for the outcome of the disease and that is (are) genetically determined. The determinant of paralysis of another neurovirulent retrovirus, ts-1 Moloney MuLV, has also recently been mapped within env, and only four amino acid residues were found to distinguish this paralytogenic strain of Moloney from the wild-type nonparalytogenic Moloney MuLV (22) . In one out of four of these amino acid positions, the Cas-Br-E sequence was identical to that of wild-type Moloney MuLV, in two sites the Cas-Br-E residue was distinct from that ofts-1 and of wild-type Moloney MuLV, and in the last site (position 7250) it was similar to that of ts-1 Moloney but also to that of other nonparalytogenic MuLVs (8) . This comparison indicates that the modifications which led to the emergence of a paralytogenic env gene in ts-1 Moloney and Cas-Br-E MuLVs are distinct.
A Model for Retrovirus-Induced CNS Spongiform Degeneration. The env region of some retroviruses has been implicated in pathogenesis. The ability of spleen-focus-forming virus (SFFV) to induce erythroleukemia has clearly been shown to be caused by its env gene product (gp55) (23) . Secondary determinants of leukemogenicity of different strains of MuLVs have also been found in the env region of these viruses (24) (25) (26) , and the gpl20 env protein ofthe human immunodeficiency virus (HIV) seems responsible for some of the cytopathic effects of the virus (27) , although its role in pathogenicity is not yet clear. The mechanism by which the env gene product (most likely gp7O) of Cas-Br-E MuLV induces spongiform degeneration within the CNS remains unclear. Since the only well-known function of retroviral env gene product is to recognize a cellular receptor to initiate infection, we propose that the Cas-Br-E MuLV produces this spongiform degeneration through binding of its gp7O to a specific cellular receptor. (i) Through this receptor, the Cas-Br-E gp7O could facilitate penetration into specific CNS cells. However, the specificity of this virus for anterior horn cells does not appear to be determined by its env gene. We have indeed previously shown that the Cas-Br-E LTR determines this topographical specificity (7) . (ii) Bound to this receptor, the gp7O (virion-associated or free) could compete with a physiological trophic factor, thus preventing its action. (iii) Alternatively, by binding to a receptor, the gp7O molecules could interfere with its normal function. For example, they could overstimulate it or they could initiate opening of ion channels or induce inappropriate synthesis of membranes or synthesis of abnormal membranes, leading to a change in plasma membrane permeability (28) and consequently to spongiform degeneration. This model assumes that Cas-Br-E gp70 has evolved to the point of recognizing a normal physiologically important CNS receptor. The env gpl20 of HIV (29) (30) (31) and several viral proteins (32) have been shown to recognize cellular receptors. The proposed model is consistent with one major feature of the pathological process, the absence of inflammation in the spongiform degenerative lesions (3, 5, 6) . If correct, this model may help to identify this receptor and its physiological ligand in the CNS. We hope that the availability of such a mouse model of retrovirusinduced CNS degenerative diseases will help us to understand the human neurological diseases induced by human retroviruses such as human T-cell leukemia virus type I (33) and HIV (34) .
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